| Financial Year |
March 31 2022 |
| Monetary Funds |
532,379,973.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
515,292,403.35 |
| Advances to Suppliers |
33,806,992.63 |
| Other Receivables |
321,304,565.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
529,779,497.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,796,095.74 |
| Total Current Assets |
1,986,359,528.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,566,904.39 |
| Investment Properties |
681,915,817.52 |
| Fixed Assetes |
265,685,410.90 |
| Under-construction Projects |
750,808,826.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
207,341,263.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,832,972.19 |
| Deferred Income Tax Assets |
444,562,014.33 |
| Other Non-Current Assets |
1,545,989.20 |
| Sub-Total of Non-Current Assets |
2,400,140,684.95 |
| Total Assets |
4,386,500,212.98 |
| Short-Term Loans |
340,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
743,423,676.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,126,627.47 |
| Taxes Payable |
-3,753,124.34 |
| Interest Payable |
-- |
| Dividend Payable |
249,686.33 |
| Other payables |
88,762,170.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
67,500,000.00 |
| Other Current Liabilities |
1,004,435.63 |
| Sub-Total of Current Liabilities |
1,496,583,368.58 |
| Long-term Loans |
627,499,999.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,000,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
647,867,767.88 |
| Total Liabilities |
2,144,451,136.46 |
| Paid-In Capital(Or Share Stock) |
1,824,667,620.00 |
| Capital Surplus |
1,763,639,784.11 |
| Surplus Reserve |
146,623,605.67 |
| LESS:Treasury Stock |
15,000,000.00 |
| Undistributed Profits |
-1,446,662,916.45 |
| Minority Stockholder's Interest |
-31,219,016.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,273,268,093.33 |
| Owner's Equity（Stockholder's Equity） |
2,242,049,076.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,386,500,212.98 |
